Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2022-08-23 00:00:00 ET · period of report 2022-08-16 · accession 0001567619-22-016597 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-23 | 2022-08-16 | PCSA | Young David | Pres, CEO, Dir, 10% | G - Gift | $0.00 | -9,250 | 377.8K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | G | D | 9,250 | $0.00 | 377,784 | D | — | — |